Migraines are being discussed in various contexts, including diagnosis, symptoms, and potential treatments. Efforts to raise awareness about migraines, particularly in pediatric cases, are also being reported. Additionally, pharmaceutical companies are working on migraine prevention pipelines, with significant funding announcements being made.